Biotec Pharmacon Asa

Thor Nøkland

Rolf Einar Engstad

The present invention relates to a glucan having a weight average molar mass of 15,000 to 50,000 g/mol on a single chain basis and a weight average molar mass in aqueous solution on an aggregate basis of 4 to 20&#xd7;10g/mol and existing in gel form in aqueous solution at a concentration &#x2265;1% at 25&#xb0; C. and neutral pH and having a melting temperature (gel to sol) of 30 to 44&#xb0; C. when the glucan is dissolved in water at a concentration of 2%, methods for the production thereof, medical uses thereof, physical supports having the glucan applied thereto or impregnated thereon and in vitro methods of proliferation of skin cells which comprise contacting a population of skin cells with the glucan.

Glucans

The present invention relates to a glucan having a weight average molar mass of 15,000 to 50,000 g/mol on a single chain basis and a weight average molar mass in aqueous solution on an aggregate basis of 4 to 20&#xd7;10g/mol and existing in gel form in aqueous solution at a concentration &#x2267;1% at 25&#xb0; C. and neutral pH and having a melting temperature (gel to sol) of 30 to 44&#xb0; C. when the glucan is dissolved in water at a concentration of 2%, methods for the production thereof, medical uses thereof, physical supports having the glucan applied thereto or impregnated thereon and in vitro methods of proliferation of skin cells which comprise contacting a population of skin cells with the glucan.

Growing community of inventors

Tromsø, Norway

Thor Nøkland